$96.68
4.30% yesterday
Nasdaq, Oct 07, 10:05 pm CET

Illumina Stock price

$96.68
-1.50 1.53% 1M
+23.23 31.63% 6M
-36.95 27.65% YTD
-43.98 31.27% 1Y
-104.20 51.87% 3Y
-219.32 69.41% 5Y
-45.51 32.01% 10Y
+89.89 1,323.67% 20Y
Nasdaq, Closing price Tue, Oct 07 2025
-4.34 4.30%

Key metrics

Basic
Market capitalization
$14.9b
Enterprise Value
$15.7b
Net debt
$836.0m
Cash
$1.2b
Shares outstanding
154.0m
Valuation (TTM | estimate)
P/E
12.1 | 21.0
P/S
3.5 | 3.4
EV/Sales
3.7 | 3.6
EV/FCF
15.2
P/B
6.6
Financial Health
Equity Ratio
37.7%
Return on Equity
-51.5%
ROCE
19.6%
ROIC
18.5%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$4.3b | $4.3b
EBITDA
$1.2b | $1.2b
EBIT
$905.0m | $961.9m
Net Income
$1.3b | $709.4m
Free Cash Flow
$1.0b
Growth (TTM | estimate)
Revenue
-3.3% | -0.6%
EBITDA
76.3% | 76.1%
EBIT
275.5% | 45.5%
Net Income
141.3% | 158.0%
Free Cash Flow
188.8%
Margin (TTM | estimate)
Gross
67.1%
EBITDA
27.6% | 26.9%
EBIT
21.1%
Net
29.4% | 16.3%
Free Cash Flow
24.1%
More
EPS
$8.0
FCF per Share
$6.7
Short interest
7.4%
Employees
9k
Rev per Employee
$490.0k
Show more

Is Illumina a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Illumina Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Illumina forecast:

13x Buy
45%
13x Hold
45%
3x Sell
10%

Analyst Opinions

29 Analysts have issued a Illumina forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,284 4,284
3% 3%
100%
- Direct Costs 1,410 1,410
16% 16%
33%
2,874 2,874
5% 5%
67%
- Selling and Administrative Expenses 977 977
19% 19%
23%
- Research and Development Expense 992 992
24% 24%
23%
1,183 1,183
76% 76%
28%
- Depreciation and Amortization 278 278
35% 35%
6%
EBIT (Operating Income) EBIT 905 905
276% 276%
21%
Net Profit 1,258 1,258
141% 141%
29%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
PRNewsWire
7 days ago
New business focuses on developing data assets, software, and AI to fuel life science breakthroughs Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO , Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ins...
Negative
Forbes
12 days ago
Amid increased competition from China's MGI Tech, Illumina's stock (NASDAQ: ILMN) has dropped by 11% in a week. MGI Tech's DNA sequencers are reportedly gaining market share, and despite a recent decline in its international sales due to U.S. sanctions, MGI Tech's global market presence remains strong.
Neutral
PRNewsWire
15 days ago
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO , Sept. 23, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test.
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 9,000
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today